Literature DB >> 7869952

Patient registration and treatment allocation in multicenter clinical trials using a FAX-OCR system.

K Akazawa1, T Kamakura, M Sakamoto, T Odaka, Y Nose.   

Abstract

This article describes the design and results of implementation of an automated patient registration and treatment allocation system (RETAS) used in multicenter clinical trials. RETAS was developed using a FAX-OCR system by which handwritten Japanese and English characters, as well as numericals and forms with check boxes, are sent from participating institutions by Fax, processed using an optical character reader, and then transmitted to a host computer at a statistical center. Based on the facsimile data, RETAS can automatically review eligibility, collect patient identification data and provide a randomized treatment allocation. RETAS permits uninterrupted, unattended operation at a statistical center, 24 hours a day, 7 days a week. Therefore, it drastically decreases the workload of personnel at the statistical center needed to support central telephone registration coverage. Consequently, staff members are free to focus on patient registration, treatment allocation, and follow-up of patients. The treatment allocation procedure in this system is based on Pocock and Simon's minimization method combined with Zelen's method for institution balancing. By this system it was possible to balance treatment numbers for each level of various prognostic factors over an entire trial and, at the same time, balance the allocation of treatments within an institution. The system currently supports the protocol of a clinical trial for Adjuvant Chemo-Endocrine Therapy for Breast Cancer in West Japan.

Entities:  

Mesh:

Year:  1994        PMID: 7869952

Source DB:  PubMed          Journal:  Methods Inf Med        ISSN: 0026-1270            Impact factor:   2.176


  3 in total

1.  Towards a common framework for clinical trials information systems.

Authors:  N C Salgado; A Gouveia-Oliveira
Journal:  Proc AMIA Symp       Date:  2000

2.  An automated patient registration and treatment randomization system.

Authors:  C Papaconstantinou; J P Krischer
Journal:  J Med Syst       Date:  1995-12       Impact factor: 4.460

3.  Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment.

Authors:  Miguel J A Láinez; Jean Schoenen; Chad Stroud; Jennifer Bardos; Mark Bangs; Phebe Kemmer; Richard Wenzel; Dulanji K Kuruppu; James Michael Martinez; Tina M Oakes
Journal:  Headache       Date:  2021-11-22       Impact factor: 5.311

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.